ANT RØNTGEN AS
Keywords
x-ray institutesblood banks
Organization
- CEO
- MS
Morten Skjesol1960
- Chairman of the board
- MS
Morten Skjesol1960
- Years since formation
- 5 years
- since Sep 23, 2020
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 150
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2024
- 640,695
- NOK
- Annual total result 2024
- 271,621
- NOK
- Total equity 2024
- 417,061
- NOK
Last update: Jul 2, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
MS 1960 | Managing Director/CEO | 100 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
MS 1960 | Chairman | 100 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
MS 1960 | Managing Director/CEO, Chairman | 100 % indirectly |
Last update: Jul 14, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 150 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2023: NOK 2,324,093Operating profit 2023: NOK 977,803Employees: 0
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 640,695 | 110,000 | 1,402,067 | 396,000 |
Annual Total Result | 271,621 | -558,597 | -15,879 | -278,010 |
Total assets | 673,213 | 525,507 | 365,500 | 467,144 |
Total liabilities | 256,152 | 380,068 | 617,948 | 703,713 |
Total equity | 417,061 | 145,440 | -252,448 | -236,569 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 640,695 | 110,000 | 1,402,067 | 396,000 |
Total operating costs | 298,716 | 533,082 | 1,408,053 | 746,317 |
Operating result | 341,979 | -423,082 | -5,986 | -350,317 |
Financial income/costs | 6,408 | -22,006 | -14,371 | -6,106 |
Profit before tax | 348,387 | -445,087 | -20,357 | -356,423 |
Total tax & extraordinary income/cost | 76,766 | 113,510 | -4,478 | -78,413 |
Annual Total Result | 271,621 | -558,597 | -15,879 | -278,010 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 39,200 | 68,400 | 211,110 | 434,832 |
Total current assets | 634,013 | 457,107 | 154,390 | 32,312 |
Total assets | 673,213 | 525,507 | 365,500 | 467,144 |
Short term debt | 179,386 | 380,068 | 617,948 | 703,713 |
Long term debt | 76,766 | 0 | 0 | 0 |
Total liabilities | 256,152 | 380,068 | 617,948 | 703,713 |
Contributed capital | 144,430 | 144,430 | 144,430 | 144,430 |
Retained earnings | 272,631 | 1,010 | -396,878 | -380,999 |
Total equity | 417,061 | 145,440 | -252,448 | -236,569 |
Total equity and liabilities | 673,213 | 525,507 | 365,500 | 467,144 |
Classification
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.9
Main industrial group
Other human health activities
86.90
Industrial group
Other human health activities
86.906
Industrial group
Medical laboratories